Sterling Investment Advisors (Pennsylvania)’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,000
| Closed | -$11K | – | 147 |
|
|
2022
Q2 | $11K | Hold |
4,000
| – | – | ﹤0.01% | 389 |
|
|
2022
Q1 | $12K | Hold |
4,000
| – | – | ﹤0.01% | 413 |
|
|
2021
Q4 | $16K | Hold |
4,000
| – | – | ﹤0.01% | 387 |
|
|
2021
Q3 | $17K | Hold |
4,000
| – | – | 0.01% | 375 |
|
|
2021
Q2 | $12K | Hold |
4,000
| – | – | ﹤0.01% | 407 |
|
|
2021
Q1 | $13K | Hold |
4,000
| – | – | ﹤0.01% | 379 |
|
|
2020
Q4 | $14K | Hold |
4,000
| – | – | ﹤0.01% | 329 |
|
|
2020
Q3 | $13K | Hold |
4,000
| – | – | 0.01% | 325 |
|
|
2020
Q2 | $7K | Hold |
4,000
| – | – | ﹤0.01% | 363 |
|
|
2020
Q1 | $4K | Hold |
4,000
| – | – | ﹤0.01% | 351 |
|
|
2019
Q4 | $11K | Hold |
4,000
| – | – | 0.01% | 331 |
|
|
2019
Q3 | $6K | Buy |
+4,000
| New | +$6K | ﹤0.01% | 363 |
|
|
2019
Q2 | – | Sell |
-3,000
| Closed | -$11K | – | 416 |
|
|
2019
Q1 | $11K | Buy |
+3,000
| New | +$11K | 0.01% | 332 |
|